AU2023352012A1 - Sterilized heterocyclidene-acetamide-derivative-containing suspension - Google Patents
Sterilized heterocyclidene-acetamide-derivative-containing suspension Download PDFInfo
- Publication number
- AU2023352012A1 AU2023352012A1 AU2023352012A AU2023352012A AU2023352012A1 AU 2023352012 A1 AU2023352012 A1 AU 2023352012A1 AU 2023352012 A AU2023352012 A AU 2023352012A AU 2023352012 A AU2023352012 A AU 2023352012A AU 2023352012 A1 AU2023352012 A1 AU 2023352012A1
- Authority
- AU
- Australia
- Prior art keywords
- suspension liquid
- aqueous suspension
- liquid formulation
- acetamide
- trifluoromethylchroman
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022-156060 | 2022-09-29 | ||
| JP2022156060 | 2022-09-29 | ||
| PCT/JP2023/035547 WO2024071348A1 (ja) | 2022-09-29 | 2023-09-28 | 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2023352012A1 true AU2023352012A1 (en) | 2025-04-03 |
Family
ID=90478164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2023352012A Pending AU2023352012A1 (en) | 2022-09-29 | 2023-09-28 | Sterilized heterocyclidene-acetamide-derivative-containing suspension |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4595959A1 (https=) |
| JP (2) | JP7589393B2 (https=) |
| KR (1) | KR20250065723A (https=) |
| CN (1) | CN119997937A (https=) |
| AU (1) | AU2023352012A1 (https=) |
| MX (1) | MX2025003326A (https=) |
| WO (1) | WO2024071348A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025206172A1 (ja) * | 2024-03-28 | 2025-10-02 | 千寿製薬株式会社 | 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ565080A (en) | 2005-07-22 | 2011-03-31 | Mochida Pharm Co Ltd | Novel heterocyclidene acetamide derivative |
| JP6230743B1 (ja) | 2017-05-31 | 2017-11-15 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の結晶 |
| CN112409191A (zh) | 2019-08-23 | 2021-02-26 | 持田制药株式会社 | 光学活性的氨基醇的制备方法 |
| PL4019485T3 (pl) | 2019-08-23 | 2024-10-21 | Mochida Pharmaceutical Co., Ltd. | Sposób wytwarzania pochodnych heterocyklidenoacetamidu |
| WO2021039023A1 (ja) | 2019-08-23 | 2021-03-04 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
| MY207759A (en) | 2019-10-04 | 2025-03-17 | Mochida Pharm Co Ltd | Pharmaceutical drug containing heterocyclidene acetamide derivative |
| JP7663009B2 (ja) | 2021-03-31 | 2025-04-16 | ニデックパワートレインシステムズ株式会社 | 回転電機、およびポンプ |
-
2023
- 2023-09-28 WO PCT/JP2023/035547 patent/WO2024071348A1/ja not_active Ceased
- 2023-09-28 JP JP2024521732A patent/JP7589393B2/ja active Active
- 2023-09-28 EP EP23872568.3A patent/EP4595959A1/en active Pending
- 2023-09-28 KR KR1020257013712A patent/KR20250065723A/ko active Pending
- 2023-09-28 CN CN202380069446.7A patent/CN119997937A/zh active Pending
- 2023-09-28 AU AU2023352012A patent/AU2023352012A1/en active Pending
-
2024
- 2024-11-13 JP JP2024198093A patent/JP2025024083A/ja active Pending
-
2025
- 2025-03-20 MX MX2025003326A patent/MX2025003326A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2025003326A (es) | 2025-05-02 |
| KR20250065723A (ko) | 2025-05-13 |
| JPWO2024071348A1 (https=) | 2024-04-04 |
| JP7589393B2 (ja) | 2024-11-25 |
| JP2025024083A (ja) | 2025-02-19 |
| CN119997937A (zh) | 2025-05-13 |
| WO2024071348A1 (ja) | 2024-04-04 |
| EP4595959A1 (en) | 2025-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2743551C (en) | Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol | |
| US20170196802A1 (en) | Long Acting Injectable Formulations | |
| TWI544934B (zh) | 含有氟喹諾酮抗生素藥物之經改良藥學組成物 | |
| RU2705376C2 (ru) | Композиции пролекарства арипипразола | |
| IL293541A (en) | Ophthalmic preparations | |
| AU2023352012A1 (en) | Sterilized heterocyclidene-acetamide-derivative-containing suspension | |
| JP7273235B2 (ja) | ヘテロシクリデンアセトアミド誘導体含有懸濁液 | |
| CA2798575C (en) | Pharmaceutical composition of ibuprofen for injection | |
| JP4188084B2 (ja) | トラマドールとジクロフェナクの塩の懸濁液を含有する非経口投与可能な剤形 | |
| CA3268119A1 (en) | Sterilized heterocyclidene-acetamide-derivative-containing suspension | |
| US10463674B2 (en) | Process for manufacturing sterile ophthalmic pharmaceutical suspensions | |
| US20260091018A1 (en) | Combination preparation containing heterocyclidene acetamide derivative | |
| KR20220144359A (ko) | 점안제로부터의 보존제 제거 | |
| WO2025206172A1 (ja) | 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物 | |
| RU2832581C1 (ru) | Офтальмологические фармацевтические композиции | |
| WO2024256956A1 (en) | Stable formulations of bilastine for nasal and ophthalmic use | |
| WO2023148763A1 (en) | Injectable pharmaceutical compositions of azole antifungal agents | |
| WO2022195382A1 (en) | A stable ophthalmic nanosupension of brinzolamide |